760
We report a 44-year-old woman with t-MDS (refractory anemia with excess blasts) following treatment of recurrent anaplastic astrocytoma with temozolomide (TMZ).
 ( adverse event: following ,  a 44-year-old woman: Subject, 44-year-old: Subject.Age, woman: Subject.Gender, a: Subject.Population, t-MDS (refractory anemia with excess blasts): Effect, treatment of recurrent anaplastic astrocytoma with temozolomide (TMZ): Treatment, recurrent anaplastic astrocytoma: Treatment.Disorder, temozolomide: Treatment.Drug) 
Locate the role in the text that participated in the event based on the event type and return it in the event list. 
 Option: Event type: adverse event,potential therapeutic event, Arguments type: Treatment.Disorder,Treatment.Time_elapsed,Treatment.Dosage,Subject.Race,Treatment.Drug,Treatment.Route,Subject.Disorder,Treatment.Freq,Treatment,Effect,Subject.Population,Treatment.Duration,Combination.Drug,Subject,Subject.Age,Subject.Gender. 
Text: {0} 
Answer:
 ( adverse event: following ,  a 44-year-old woman: Subject, 44-year-old: Subject.Age, woman: Subject.Gender, a: Subject.Population, t-MDS (refractory anemia with excess blasts): Effect, treatment of recurrent anaplastic astrocytoma with temozolomide (TMZ): Treatment, recurrent anaplastic astrocytoma: Treatment.Disorder, temozolomide: Treatment.Drug) 